Strong evidence on a question of major public interest
Paracetamol is among the most commonly used pain-relieving and fever-reducing medicines worldwide, including in pregnancy. In recent years, claims of a possible link between paracetamol exposure during pregnancy and autism have received significant public attention. This has created understandable anxiety and, in some settings, complicated clinical discussions about how to manage pain and fever safely during pregnancy.
The newly published study addresses these concerns using large-scale, population-based data and rigorous analytical methods. By drawing on robust datasets and carefully designed analyses, the collaboration provides important evidence to inform clinical practice and public health communication. The overall conclusion is clear: the study found no evidence supporting an association between paracetamol use during pregnancy and autism in children.
Contribution from the Department of Biomaterials
Our associate professor, Athina Samara, contributed to the European scientific team in this international collaboration. Participation in high-impact, multi-centre research of this kind is essential for strengthening the evidence base that guides patient care—particularly when the topic is both medically relevant and widely discussed in the media and among the public.
For the Department of Biomaterials, the study also aligns with broader research priorities at the intersection of pain management, human development, and advanced model systems. Understanding biological development and responses to external exposures—while maintaining a strong methodological foundation—supports the department’s long-term work in translational research and tissue reconstruction.
Global attention following publication
Following publication, the study received extensive international media coverage, reflecting the high public interest and its relevance to healthcare guidance. Major outlets such as Reuters and the Financial Times highlighted the findings, and the journal’s announcement on X gained exceptional visibility, reaching nearly 700,000 views within a week.
While media attention can sometimes amplify uncertainty, this case illustrates how well-conducted research can help clarify complex questions and support informed decision-making. The study’s reach also underscores the importance of communicating robust evidence clearly—especially on topics that directly affect families and clinical guidance.
Relevance for evidence-based patient care
The findings represent an important contribution to evidence-based care and public health. For clinicians, the study strengthens the foundation for conversations with patients about common medication use during pregnancy. For expectant parents, it offers reassurance grounded in large-scale data rather than speculation.
Further research perspectives
In addition to this contribution, Athina and colleagues are engaged in research on advanced 3D model systems to study human development relevant to tissue reconstruction. Such approaches are part of a broader commitment to developing refined, human-relevant experimental models that can improve our understanding of biological processes and ultimately support safer, more effective clinical strategies.
We are proud to see our staff contributing to internationally visible research with clear real-world relevance—research that informs public discussion, supports clinicians, and helps address concerns among expectant parents worldwide.